SEC Form 4 · accession 0001209191-15-030533
Kite Pharma, Inc. · KITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ran Nussbaum
Director
Period of report
Mar 27, 2015
Accepted (ET)
Mar 31, 2015 · 8:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510580
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Mar 27, 2015 | S | 13,936 | $61.241 | D | 216,064 | I | See Footnote |
| Common StockF4,F3,F5 | Mar 27, 2015 | S | 13,937 | $61.241 | D | 136,063 | I | See Footnote |
| Common StockF6,F3,F7 | Mar 27, 2015 | S | 50,000 | $61.241 | D | 70,000 | I | See Footnote |
| Common StockF2,F3 | Mar 30, 2015 | S | 66,948 | $59.9141 | D | 149,116 | I | See Footnote |
| Common StockF3,F5 | Mar 30, 2015 | S | 23,349 | $59.9141 | D | 112,714 | I | See Footnote |
| Common StockF8,F3,F7 | Mar 30, 2015 | S | 25,560 | $59.9141 | D | 43,604 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The number of shares reflects the disposition of 846,390 shares in a pro-rata distribution from the partnership identified in Column 7 to its partners on March 27, 2015. In prior reports, the Reporting Person has reported all shares of the Issuer's common stock owned by the partnership.
- F2The securities are held in the name of Pontifax (Cayman) II L.P.
- F3The reporting person is a director of Pontifax Management 2 G.P. (2007) Ltd., the general partner of Pontifax (Cayman) II, L.P., Pontifax (Israel) II, L.P. and Pontifax (Israel) II - Individual Investors L.P.
- F4The number of shares reflects the disposition of 660,803 shares in a pro-rata distribution from the partnership identified in Column 7 to its partners on March 27, 2015. In prior reports, the Reporting Person has reported all shares of the Issuer's common stock owned by the partnership.
- F5The securities are held in the name of Pontifax (Israel) II, L.P.
- F6The number of shares reflects the disposition of 194,743 shares in a pro-rata distribution from the partnership identified in Column 7 to its partners on March 27, 2015. In prior reports, the Reporting Person has reported all shares of the Issuer's common stock owned by the partnership.
- F7The securities are held in the name of Pontifax (Israel) II - Individual Investors L.P.
- F8The number of shares reflects the disposition of 836 shares in a pro-rata distribution from the partnership identified in Column 7 to its partners on March 30, 2015. In prior reports, the Reporting Person has reported all shares of the Issuer's common stock owned by the partnership.